BR112022019191A2 - 25-hidroxivitamina d2 e/ou d3 para uso em obesidade - Google Patents

25-hidroxivitamina d2 e/ou d3 para uso em obesidade

Info

Publication number
BR112022019191A2
BR112022019191A2 BR112022019191A BR112022019191A BR112022019191A2 BR 112022019191 A2 BR112022019191 A2 BR 112022019191A2 BR 112022019191 A BR112022019191 A BR 112022019191A BR 112022019191 A BR112022019191 A BR 112022019191A BR 112022019191 A2 BR112022019191 A2 BR 112022019191A2
Authority
BR
Brazil
Prior art keywords
vitamin
combination
obesity
people
treatment
Prior art date
Application number
BR112022019191A
Other languages
English (en)
Inventor
M Müller Peter
F Holick Michael
Original Assignee
Carbogen Amcis B V
Aamanya Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carbogen Amcis B V, Aamanya Ag filed Critical Carbogen Amcis B V
Publication of BR112022019191A2 publication Critical patent/BR112022019191A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

25-HIDROXIVITAMINA D2 E/OU D3 PARA USO EM OBESIDADE. A presente invenção refere-se ao campo de insuficiência e deficiência de vitamina D, a saber, níveis sanguíneos muito baixos de 25(OH)D, e à sua prevenção e tratamento. Fornece um suplemento de vitamina D que compreende (i) uma combinação de 25(OH)D3 e/ou 25(OH)D2 e vitamina D2; ou (ii) uma combinação de 25(OH)D3 e/ou 25(OH)D2 e vitamina D3; ou (iii) uma combinação de 25(OH)D3 e/ou 25(OH)D2 e uma combinação de vitamina D2 e vitamina D3, para uso no tratamento e/ou profilaxia de insuficiência ou deficiência de vitamina D em pessoas obesas, pessoas com sobrepeso tendo tendência à obesidade ou pessoas tendo histórico de má absorção de vitamina D, ou pessoas com uma predisposição genética para desenvolver obesidade. São também fornecidas composições e regimes de dosagem correspondentes compreendendo tais suplementos de vitamina D, bem como kits compreendendo tais composições. Além disso, regimes de dosagem correspondentes para administração diária e bulas de produto correspondentes também são fornecidos. A invenção também se refere a métodos de tratamento correspondentes.
BR112022019191A 2020-04-07 2021-04-06 25-hidroxivitamina d2 e/ou d3 para uso em obesidade BR112022019191A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20168450 2020-04-07
EP20170350 2020-04-20
PCT/EP2021/058958 WO2021204812A2 (en) 2020-04-07 2021-04-06 Novel use of 25-hydroxyvitamin d

Publications (1)

Publication Number Publication Date
BR112022019191A2 true BR112022019191A2 (pt) 2022-11-01

Family

ID=75377820

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022019191A BR112022019191A2 (pt) 2020-04-07 2021-04-06 25-hidroxivitamina d2 e/ou d3 para uso em obesidade

Country Status (6)

Country Link
US (1) US20230248744A1 (pt)
EP (1) EP4132534A2 (pt)
CN (1) CN115397432A (pt)
BR (1) BR112022019191A2 (pt)
MX (1) MX2022012599A (pt)
WO (1) WO2021204812A2 (pt)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2148684E (pt) 2007-04-25 2013-04-19 Cytochroma Inc Método de tratamento para a insuficiência e deficiência de vitamina d
HRP20231142T3 (hr) * 2007-04-25 2024-01-05 Eirgen Pharma Ltd. Kontrolirano oslobađanje 25-hidroksivitamina d
CA2693160C (en) 2007-07-18 2016-09-20 Schlumberger Canada Limited System and method to measure dielectric constant in a subterranean well
KR20150139629A (ko) * 2008-02-13 2015-12-11 디에스엠 아이피 어셋츠 비.브이. 비타민 ｄ와 25-하이드록시비타민 ｄ3의 조합물
WO2009124210A1 (en) * 2008-04-02 2009-10-08 Cytochroma Inc. Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
RU2020135926A (ru) 2018-04-03 2022-05-04 Опко Айэлэнд Глобал Холдингз, Лтд. Применение кальцифедиола у пациентов, перенесших бариатрическую операцию

Also Published As

Publication number Publication date
US20230248744A1 (en) 2023-08-10
WO2021204812A2 (en) 2021-10-14
MX2022012599A (es) 2022-11-07
EP4132534A2 (en) 2023-02-15
CN115397432A (zh) 2022-11-25
WO2021204812A3 (en) 2022-03-17

Similar Documents

Publication Publication Date Title
Koutkia et al. Treatment of vitamin D deficiency due to Crohn's disease with tanning bed ultraviolet B radiation
Dumville et al. Can vitamin D supplementation prevent winter-time blues? A randomised trial among older women
Mangels Bone nutrients for vegetarians
American Geriatrics Society Workgroup on Vitamin D Supplementation for Older Adults Recommendations abstracted from the American Geriatrics Society consensus statement on vitamin D for prevention of falls and their consequences
Desneves et al. Treatment with supplementary arginine, vitamin C and zinc in patients with pressure ulcers: a randomised controlled trial
Allender et al. Dietary calcium and blood pressure: a meta-analysis of randomized clinical trials
Muñoz-Aguirre et al. The effect of vitamin D supplementation on serum lipids in postmenopausal women with diabetes: a randomized controlled trial
Li et al. Vitamin D status and its relationship with body composition, bone mineral density and fracture risk in urban central south Chinese postmenopausal women
BR0208640A (pt) Suplemento nutricional para tratar degeneração macular
BR0113367A (pt) Composição nutricional
Duque et al. Vitamin D, bones and muscle: myth versus reality
BRPI0517132A (pt) regime de cladribina para o tratamento da esclerose múltipla
Ilesanmi‐Oyelere et al. B vitamins and homocysteine as determinants of bone health: A literature review of human studies
Blufstein et al. Transcriptional activity of vitamin D receptor in human periodontal ligament cells is diminished under inflammatory conditions
Raymond-Lezman et al. Benefits and risks of sun exposure to maintain adequate vitamin D levels
BR112022019191A2 (pt) 25-hidroxivitamina d2 e/ou d3 para uso em obesidade
Vani et al. Effects of vitamin D and calcium supplementation on side effects profile in patients of breast cancer treated with letrozole
Kosmowska-Miśków The role of vitamin D3 in inflammatory bowel diseases
Akinola et al. Effects of severe malnutrition on oxidative stress in Wistar rats.
King The Role of Vitamin D deficiency in COVID-19 related deaths in BAME, Obese and Other High-risk Categories
BRPI0411429A (pt) tratamento de sintomas associados com vaginose bacteriana
BR112022017110A2 (pt) Composições e uso das mesmas
Noori et al. Assessment of vitamin K2 levels in osteoporotic patients: a case control study
Nowaczek et al. Vegan and vegetarian diet influence on bone health-a short review
Dalvi et al. Study of vitamins in pulmonary tuberculosis